Oncotelic Therapeutics, Inc (OTLC)
0.04
0.00 (0.00%)
Upcoming Events
Latest Headlines
Form 4 Oncotelic Therapeutics, For: Jul 10 Filed by: KING STEVEN W
July 21, 2026 4:01 PM - SEC Filing
Form 8-K Oncotelic Therapeutics, For: Jul 13
July 14, 2026 4:00 PM - SEC Filing
Form 8-K Oncotelic Therapeutics, For: Jul 10
July 14, 2026 4:00 PM - SEC Filing
Form 4 Oncotelic Therapeutics, For: Jul 10 Filed by: Trieu Vuong
July 14, 2026 4:00 PM - SEC Filing
Form 4 Oncotelic Therapeutics, For: Jul 10 Filed by: Shah Amit B.
July 14, 2026 4:00 PM - SEC Filing
Form 4 Oncotelic Therapeutics, For: Jul 10 Filed by: Saund Saran
July 14, 2026 4:00 PM - SEC Filing
Form 4 Oncotelic Therapeutics, For: Jul 10 Filed by: MAIDA ANTHONY E III
July 14, 2026 4:00 PM - SEC Filing
Form 4 Oncotelic Therapeutics, For: Jul 01 Filed by: Trieu Vuong
July 2, 2026 3:00 PM - SEC Filing
Form 8-K Oncotelic Therapeutics, For: Jun 23
June 29, 2026 5:15 PM - SEC Filing
Form 4 Oncotelic Therapeutics, For: Jun 22 Filed by: Trieu Vuong
June 24, 2026 8:38 PM - SEC Filing
Form 4 Oncotelic Therapeutics, For: Jun 22 Filed by: Shah Amit B.
June 22, 2026 4:30 PM - SEC Filing
Form 4 Oncotelic Therapeutics, For: Jun 15 Filed by: Trieu Vuong
June 17, 2026 7:34 PM - SEC Filing
Oncotelic Therapeutics Files First Quarter 2026 Financial Results and Strategic Progress
May 15, 2026 9:00 AM - Globe NewsWire
NetworkNews Audio Announces Audio Press Release (APR) Discussing Developing Technologies Designed to Bypass BBB Limitations
May 15, 2026 8:30 AM - Globe NewsWire
Form 10-Q Oncotelic Therapeutics, For: Mar 31
May 14, 2026 5:16 PM - SEC Filing
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Responds to BBB Challenge with Next-Gen Drug-Delivery Platform
May 14, 2026 8:30 AM - Globe NewsWire
CNS Drug Delivery Technologies Are Reshaping Alzheimer’s and Biodefense Research
May 13, 2026 8:30 AM - Globe NewsWire
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Proprietary N2B System May Offer Key to Unlocking Next-Gen Therapies
May 12, 2026 8:30 AM - Globe NewsWire
CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities
May 11, 2026 8:30 AM - Globe NewsWire
Oncotelic Therapeutics Announces Closing of a Strategic Monetization of Its CNS/Nasal Assets with Lunai Bioworks, Advancing Joint Development in Biodefense and Alzheimer’s Disease
May 6, 2026 8:30 AM - Globe NewsWire
Form 8-K Oncotelic Therapeutics, For: May 01
May 5, 2026 4:22 PM - SEC Filing
NetworkNews Audio Announces Audio Press Release (APR) Discussing Advancing Oncology Therapeutics, Strategic Positioning within High-Value Development Pathways
April 24, 2026 8:30 AM - Globe NewsWire
Oncotelic Therapeutics Provides Corporate Update on Partnership Strategy
April 24, 2026 8:00 AM - Globe NewsWire
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Real-World Example of Scientific Advancement Influence on Evaluation
April 23, 2026 8:31 AM - Globe NewsWire
Full Article List
